Neogenomics, Inc.
NEO
$7.42
$0.294.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.55% | 10.57% | 10.44% | 11.97% | 13.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.55% | 10.57% | 10.44% | 11.97% | 13.86% |
| Cost of Revenue | 4.43% | 7.71% | 3.68% | 5.72% | 10.15% |
| Gross Profit | 11.88% | 14.31% | 20.17% | 21.04% | 19.44% |
| SG&A Expenses | 5.66% | 9.75% | 2.75% | 7.32% | 10.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.21% | 8.79% | 4.53% | 6.42% | 10.02% |
| Operating Income | 1.22% | 7.35% | 36.23% | 23.95% | 7.31% |
| Income Before Tax | 7.31% | -5.51% | 16.79% | 28.61% | 17.91% |
| Income Tax Expenses | 142.90% | 16.25% | 94.89% | 83.76% | 78.80% |
| Earnings from Continuing Operations | 4.21% | -6.97% | 4.41% | 23.38% | 12.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.21% | -6.97% | 4.41% | 23.38% | 12.13% |
| EBIT | 1.22% | 7.35% | 36.23% | 23.95% | 7.31% |
| EBITDA | -1.97% | 90.44% | 199.31% | 73.25% | 21.15% |
| EPS Basic | 5.17% | -5.89% | 5.36% | 24.01% | 12.87% |
| Normalized Basic EPS | -0.48% | 2.62% | 45.06% | 26.47% | 13.65% |
| EPS Diluted | 5.17% | -5.89% | 6.67% | 22.72% | 14.16% |
| Normalized Diluted EPS | -0.48% | 2.62% | 45.06% | 26.47% | 13.65% |
| Average Basic Shares Outstanding | 1.00% | 0.98% | 1.01% | 0.84% | 0.87% |
| Average Diluted Shares Outstanding | 1.00% | 0.98% | 1.01% | 0.84% | 0.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |